Skip to main content
Monthly Archives

September 2021

ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer’s, Parkinson’s, and Other Neuro-Degenerative Diseases Press Releases

ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer’s, Parkinson’s, and Other Neuro-Degenerative Diseases

NEWS PROVIDED BY Innovative California Biosciences International, Inc.  Sep 22, 2021, 20:26 ET LA JOLLA,…
ICBII
September 22, 2021
Close Menu